Cover Image
市場調查報告書

疼痛管理治療藥市場 (治療藥物別:抗痙攣劑,抗憂鬱劑,麻醉劑,非類固醇抗發炎性藥 (NSAID),其他,各適應症) - 全球產業分析,規模,佔有率,成長,趨勢,及2017∼2025年的預測

Pain Management Therapeutics Market (Therapeutics-Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), , & Others; Indication)-Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025

出版商 Transparency Market Research 商品編碼 587877
出版日期 內容資訊 英文 166 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
疼痛管理治療藥市場 (治療藥物別:抗痙攣劑,抗憂鬱劑,麻醉劑,非類固醇抗發炎性藥 (NSAID),其他,各適應症) - 全球產業分析,規模,佔有率,成長,趨勢,及2017∼2025年的預測 Pain Management Therapeutics Market (Therapeutics-Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), , & Others; Indication)-Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2017 - 2025
出版日期: 2017年11月07日 內容資訊: 英文 166 Pages
簡介

本報告提供全球疼痛管理治療藥市場相關調查,彙整市場概要和各治療藥物別,各適應症,及地區別趨勢,打入市場的主要企業簡介等資料。

第1章 序論

第2章 研究途徑和調查方法

第3章 摘要整理

第4章 市場定義

  • 產品概要
  • 主要的產業趨勢
  • 市場機會地圖
  • 波特五力分析
  • 市場預測

第5章 市場趨勢

  • 促進因素與阻礙因素概要分析
  • 促進要素
  • 阻礙要素
  • 機會
  • 趨勢
  • 全球最常見的疼痛部位
  • 開發平台分析
  • FDA核准類鴉片物質
  • 市場價值
  • 市場預測

第6章 不同治療市場分析

  • 主要調查結果
  • 簡介
  • 市場價值佔有率分析
  • 市場預測
    • 市場價值佔有率分析
    • 抗痙攣劑
    • 抗憂鬱劑
    • 麻醉劑
    • 非類固醇抗發炎性藥 (NSAID)
    • 類鴉片物質
    • 抗偏頭痛藥
    • 其他
  • 市場分析
  • 市場魅力度分析

第7章 各適應症市場分析

  • 主要調查結果
  • 簡介
  • 市場價值佔有率分析
  • 市場預測
    • 神經性疼痛
    • 纖維肌痛
    • 關節痛
    • 慢性腰痛
    • 偏頭痛
    • 手術後疼痛
    • 癌症的疼痛
  • 市場魅力度分析

第8章 各地區市場分析

  • 各國方案
  • 市場價值佔有率分析
  • 市場規模與預測
  • 市場魅力度分析

第9章 北美市場

第10章 歐洲市場

第11章 亞太地區市場

第12章 其他各國市場

第13章 競爭環境

  • 競爭矩陣
  • 熱圖分析
  • 企業簡介
    • Pfizer Inc.
    • Depomed, Inc.
    • Endo International plc.
    • Purdue Pharma L.P.
    • Mallinckrodt Pharmaceuticals
    • Teva Pharmaceutical Industries Ltd.
    • Novartis AG
    • AstraZeneca plc.
    • Johnson & Johnson Services, Inc.
    • Merck & Co., Inc.
    • Abbott Laboratories
    • GlaxoSmithKline plc.
目錄

Title:
Pain Management Therapeutics Market (Therapeutics - Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids, Other Non-narcotic Analgesic, and Antimigraine Agents; Indication - Neuropathic Pain, Fibromyalgia, Arthritic Pain, Chronic Back Pain, Migraine, Post-Operative Pain, and Cancer Pain) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025.

Global Pain Management Therapeutics Market: Overview

This report on the pain management therapeutics market studies the current as well as future prospects of the market globally. The pain management therapeutics market report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the general information and data analysis of the global pain management therapeutics market with respect to the leading market segments based on major therapeutics, and geographies.

Global Pain Management Therapeutics Market: Market Dynamics

The market overview section of the report explores the dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the pain management therapeutics market and could influence the market in the near future. Market attractiveness analysis has been provided in the overview section in order to explain the intensity of competition across different geographies. The competitive scenario among different players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their position and expand their shares in the global pain management therapeutics market.

Global Pain Management Therapeutics Market: Market Segmentation

The global pain management therapeutics market has been studied based on major segments by therapeutics, by indication and their regional as well as national markets. Based on therapeutics, the global market has been segmented into anticonvulsants, antidepressants, anesthetics, non-steroidal anti-inflammatory drugs (NSAIDS), opioids, other non-narcotic analgesic, and antimigraine agents. Further the market has been segmented according to its indication that includes neuropathic pain, fibromyalgia, arthritic pain, chronic back pain, migraine, post-operative pain, and cancer pain. The market for these segments has been extensively analyzed based on their effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2015-2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all segments, considering 2016 as the base year.

Geographically, the pain management therapeutics market has been segmented into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). Each regional pain management therapeutics market has been further categorized into major national markets such as the U.S, Canada, Germany, the U.K., Japan, China, Brazil, and Mexico. Market revenue in terms of US$ Mn for the period from 2015-2025 along with CAGR % from 2017 to 2025 are provided for all the regions and nations considering 2016 as the base year.

Global Pain Management Therapeutics Market: Competitive Landscape

The competition landscape section included in the report would assist existing market players to expand their market shares, and new companies in establishing their presence in the global pain management therapeutics market. The report also profiles key players operating in this market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Pfizer Inc., Depomed, Inc., Endo International plc. , Purdue Pharma L.P., Mallinckrodt Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Abbott Laboratories, GlaxoSmithKline plc., and other prominent players.

The global pain management therapeutics market is segmented as follows:

Global Pain Management Therapeutics Market Revenue, by Therapeutics

  • Anticonvulsants
  • Antidepressants
  • Anesthetics
  • Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  • Opioids
  • Oxycodones
  • Hydrocodones
  • Tramadol
  • Others (Morphine, Codeine, Fentanyl, Meperidine, Methadone)
  • Antimigraine Agents
  • Other Non-narcotic Analgesic

Global Pain Management Therapeutics Market Revenue, by Indication

  • Neuropathic Pain
  • Fibromyalgia
  • Chronic Back Pain
  • Arthritic Pain
  • Migraine
  • Post-operative Pain
  • Cancer Pain

Global Pain Management Therapeutics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
    • Australia & New Zealand
    • Rest of APAC
  • Rest of the World (RoW)

Table of Contents

Section 1: Preface

  • 1.1. Report Scope
  • 1.2. Market Segmentation
  • 1.3. Research Highlights

Section 2: Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Acronyms Used
  • 2.3. Research Methodology

Section 3: Executive Summary

Section 4: Market Overview

  • 4.1. Product Overview
  • 4.2. Key Industry Developments
  • 4.3. Market Opportunity Map
  • 4.4. Porter's Analysis
  • 4.5. Global Pain Management Therapeutics Market Outlook

Section 5: Market Dynamics

  • 5.1. Drivers and Restraints Snapshot Analysis
  • 5.2. Drivers
  • 5.3. Restraints
  • 5.4. Opportunities
  • 5.5. Trends
  • 5.6. Most Types of Body Pain Location Globally and Cut by Gender and Parents
  • 5.7. Pain Management Therapeutics Pipeline Analysis. Snapshot
  • 5.8. Opioids with FDA-Approved Labeling Describing Abuse-Deterrent Properties
  • 5.9. Global Pain Management Therapeutics Market Value (Revenue)
  • 5.10. Pain Management Therapeutics Market Outlook

Section 6: Pain Management Therapeutics Market Analysis, by Therapeutics Type

  • 6.1. Key Findings
  • 6.2. Introduction
  • 6.3. Global Pain Management Therapeutics Market Value Share Analysis, by Therapeutics Type
  • 6.4. Global Pain Management Therapeutics Market Forecast, by Therapeutics Type
    • 6.4.1. Global Pain Management Therapeutics Market Value Share Analysis, by Opioids
    • 6.4.2. Global Pain Management Therapeutics Market Forecast, by Opioids
    • 6.4.3. Global Anticonvulsants Therapeutics Market, US$ Mn, 2015-2025
    • 6.4.4. Global Antidepressants Therapeutics Market, US$ Mn, 2015-2025
    • 6.4.5. Global Anesthetics Therapeutics Market, US$ Mn, 2015-2025
    • 6.4.6. Global NSAIDs Therapeutics Market, US$ Mn, 2015-2025
    • 6.4.7. Global Opioids Therapeutics Market, US$ Mn, 2015-2025
    • 6.4.8. Global Ant migraine Agents Therapeutics Market, US$ Mn, 2015-2025
    • 6.4.9. Global Other Non-narcotic Analgesics Therapeutics Market, US$ Mn, 2015-2025
  • 6.5. Global Pain Management Therapeutics Market Analysis, by Therapeutics
  • 6.6. Global Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics

Section 7: Global Pain Management Therapeutics Market Analysis, by Indication

  • 7.1. Key Findings
  • 7.2. Introduction
  • 7.3. Global Pain Management Therapeutics Market Value Share Analysis, By Indication, 2016 and 2025
  • 7.4. Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, By Indication, 2015-2025
    • 7.4.1. Global Neuropathic Pain Market, US$ Mn, 2015-2025
    • 7.4.2. Global Fibromyalgia Market, US$ Mn, 2015-2025
    • 7.4.3. Global Arthritic Pain Market, US$ Mn, 2015-2025
    • 7.4.4. Global Chronic Back Pain Market, US$ Mn, 2015-2025
    • 7.4.5. Global Migraine Market, US$ Mn, 2015-2025
    • 7.4.6. Global Post-Operative Pain Market, US$ Mn, 2015-2025
    • 7.4.7. Global Cancer Pain Market, US$ Mn, 2015-2025
  • 7.5. Global Pain Management Therapeutics Market Attractiveness By Indication

Section 8: Pain Management Therapeutics Market Analysis, by Region

  • 8.1. Global Scenario, by Country
  • 8.2. Global Pain Management Therapeutics Market Value Share Analysis By Region, 2016 and 2025
  • 8.3. Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, By Region, 2015-2025
  • 8.4. Global Pain Management Therapeutics Market Attractiveness Analysis, by Region

Section 9: North America Pain Management Therapeutics Market Analysis

  • 9.1. Key Findings
  • 9.2. North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017-2025
  • 9.3. North America Market Attractiveness Analysis, by Country
  • 9.4. North America Market Value Share Analysis, by Country, 2017 and 2025
  • 9.5. North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country Type, 2015-2025
  • 9.4. North America Market Value Share Analysis, by Therapeutics, 2017 and 2025
  • 9.5. North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics Type, 2015-2025
    • 9.5.1. North America Pain Management Therapeutics Market Value Share Analysis, by Opioids
    • 9.5.2. North America Pain Management Therapeutics Market Forecast, by Opioids
  • 9.6. North America Market Value Share Analysis, by Indication, 2017 and 2025
  • 9.7. North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015-2025
  • 9.8. North America Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
  • 9.9. North America Pain Management Therapeutics Market Attractiveness Analysis, by Indication

Section 10: Europe Pain Management Therapeutics Market Analysis

  • 10.1. Key Findings
  • 10.2. Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017-2025
  • 10.3. Europe Market Attractiveness Analysis, by Country
  • 10.4. Europe Market Value Share Analysis, by Country, 2017 and 2025
  • 10.5. Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country Type, 2015-2025
    • 10.5.1. Europe Pain Management Therapeutics Market Value Share Analysis, by Opioids
    • 10.5.2. Europe Pain Management Therapeutics Market Forecast, by Opioids
  • 10.6. Europe Market Value Share Analysis, by Indication, 2017 and 2025
  • 10.7. Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015-2025
  • 10.8. Europe Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
  • 10.9. Europe Pain Management Therapeutics Market Attractiveness Analysis, by Indication

Section 11: Asia Pacific Pain Management Therapeutics Market Analysis

  • 11.1. Key Findings
  • 11.2. Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017-2025
  • 11.3. Asia Pacific Market Attractiveness Analysis, by Country
  • 11.4. Asia Pacific Market Value Share Analysis, by Country, 2017 and 2025
  • 11.5. Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country Type, 2015-2025
    • 11.5.1. Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Opioids
    • 11.5.2. Asia Pacific Pain Management Therapeutics Market Forecast, by Opioids
  • 11.6. Asia Pacific Market Value Share Analysis, by Indication, 2017 and 2025
  • 11.7. Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015-2025
  • 11.8. Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
  • 11.9. Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Indication

Section 12: Rest of the World Pain Management Therapeutics Market Analysis

  • 12.1. Key Findings
  • 12.2. Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2017-2025
  • 12.3. Rest of the World Market Value Share Analysis, by Therapeutics, 2017 and 2025
  • 12.4. Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics Type, 2015-2025
    • 12.4.1. Rest of the World Pain Management Therapeutics Market Value Share Analysis, by Opioids
    • 12.4.2. Rest of the World Pain Management Therapeutics Market Forecast, by Opioids
  • 12.5. Rest of the World Market Value Share Analysis, by Indication, 2017 and 2025
  • 12.6. Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication Type, 2015-2025
  • 12.7. Rest of the World Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics
  • 12.8. Rest of the World Pain Management Therapeutics Market Attractiveness Analysis, by Indication

Section 13: Competition Landscape

  • 13.1. Competition Matrix
  • 13.2. Heat Map Analysis
  • 13.3. Company Profiles
    • 13.3.1. Pfizer Inc.
      • 13.3.1.1. Company Details
      • 13.3.1.2. Business Overview
      • 13.3.1.3. Financial Overview
      • 13.3.1.4. Strategic Overview
      • 13.3.1.5. SWOT Analysis
    • 13.3.2. Depomed, Inc.
      • 13.3.2.1. Company Details
      • 13.3.2.2. Business Overview
      • 13.3.2.3. Financial Overview
      • 13.3.2.4. Strategic Overview
      • 13.3.2.5. SWOT Analysis
    • 13.3.3. Endo International plc.
      • 13.3.3.1. Company Details
      • 13.3.3.2. Business Overview
      • 13.3.3.3. Financial Overview
      • 13.3.3.4. Strategic Overview
      • 13.3.3.5. SWOT Analysis
    • 13.3.4. Purdue Pharma L.P.
      • 13.3.4.1. Company Details
      • 13.3.4.2. Business Overview
      • 13.3.4.3. Financial Overview
      • 13.3.4.4. Strategic Overview
      • 13.3.4.5. SWOT Analysis
    • 13.3.5. Mallinckrodt Pharmaceuticals
      • 13.3.5.1. Company Details
      • 13.3.5.2. Business Overview
      • 13.3.5.3. Financial Overview
      • 13.3.5.4. Strategic Overview
      • 13.3.5.5. SWOT Analysis
    • 13.3.6. Teva Pharmaceutical Industries Ltd.
      • 13.3.6.1. Company Details
      • 13.3.6.2. Business Overview
      • 13.3.6.3. Financial Overview
      • 13.3.6.4. Strategic Overview
      • 13.3.6.5. SWOT Analysis
    • 13.3.7. Novartis AG
      • 13.3.7.1. Company Details
      • 13.3.7.2. Business Overview
      • 13.3.7.3. Financial Overview
      • 13.3.7.4. Strategic Overview
      • 13.3.7.5. SWOT Analysis
    • 13.3.8. AstraZeneca plc.
      • 13.3.8.1. Company Details
      • 13.3.8.2. Business Overview
      • 13.3.8.3. Financial Overview
      • 13.3.8.4. Strategic Overview
      • 13.3.8.5. SWOT Analysis
    • 13.3.9. Johnson. Johnson Services, Inc.
      • 13.3.9.1. Company Details
      • 13.3.9.2. Business Overview
      • 13.3.9.3. Financial Overview
      • 13.3.9.4. Strategic Overview
      • 13.3.9.5. SWOT Analysis
    • 13.3.10. Merck. Co., Inc.
      • 13.3.10.1. Company Details
      • 13.3.10.2. Business Overview
      • 13.3.10.3. Financial Overview
      • 13.3.10.4. Strategic Overview
      • 13.3.10.5. SWOT Analysis
    • 13.3.11. Abbott Laboratories
      • 13.3.11.1. Company Details
      • 13.3.11.2. Business Overview
      • 13.3.11.3. Financial Overview
      • 13.3.11.4. Strategic Overview
      • 13.3.11.5. SWOT Analysis
    • 13.3.12. GlaxoSmithKline plc.
      • 13.3.11.1. Company Details
      • 13.3.11.2. Business Overview
      • 13.3.11.3. Financial Overview
      • 13.3.11.4. Strategic Overview
      • 13.3.11.5. SWOT Analysis

List of Tables

  • Table 01: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015-2025
  • Table 02: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Opioids, 2015-2025
  • Table 03: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015-2025
  • Table 04: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • Table 05: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country, 2015- 2025
  • Table 06: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015-2025
  • Table 07: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Opioids, 2015- 2025
  • Table 08: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015- 2025
  • Table 09: Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • Table 10: Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015-2025
  • Table 11: Europe Pain Management Therapeutics Market Revenue (US$ Mn) Forecast, by Opioids, 2015-2025
  • Table 12: Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015-2025
  • Table 13: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015-2025
  • Table 14: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015- 2025
  • Table 15: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Opioids, 2015-2025
  • Table 16: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015-2025
  • Table 17: Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Therapeutics, 2015-2025
  • Table 18: Rest of the World Opioids Market Revenue, by Therapeutic, (US$ Mn), 2015-2025
  • Table 19: Rest of the World Pain Management Therapeutics Market Size (US$ Mn) Forecast, by Indication, 2015-2025
  • Table 20: List of Other Prominent Players
  • Table 21: List of Other Prominent Players
  • Table 22: List of Other Prominent Players

List of Figures

  • Figure 01: Global Pain Management Therapeutics Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 02: Market Value Share, by Region (2016)
  • Figure 03: Market Value Share, by Therapeutics (2016)
  • Figure 04: Market Value Share, by Opioids (2016)
  • Figure 05: Market Value Share, by Indication (2016)
  • Figure 06: Global Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2016 and 2025
  • Figure 07: Global Pain Management Therapeutics Market Value Share Analysis, by Opioids, 2016 and 2025
  • Figure 08: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anticonvulsants, 2015-2025
  • Figure 09: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Antidepressants, 2015-2025
  • Figure 10: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Anesthetics, 2015-2025
  • Figure 11: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by NSAIDs, 2015-2025
  • Figure 12: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Opioids, 2015-2025
  • Figure 13: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ant migraine Agents, 2015-2025
  • Figure 14: Global Pain Management Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Other Non-narcotic Analgesics, 2015-2025
  • Figure 15: Global Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics, 2017-2025
  • Figure 16: Global Pain Management Therapeutics Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 17: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Neuropathic Pain, 2015-2025
  • Figure 18: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Fibromyalgia , 2015-2025
  • Figure 19: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Arthritic Pain, 2015-2025
  • Figure 20: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Chronic Back Pain , 2015-2025
  • Figure 21: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Migraine, 2015-2025
  • Figure 22: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Post-Operative Pain, 2015- 2025
  • Figure 23: Global Pain Management Therapeutics Market Revenue (US$ Mn), by Cancer Pain, 2015-2025
  • Figure 24: Global Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2015-2025
  • Figure 25: Global Pain Management Therapeutics Market Value Share Analysis, by Region, 2016 and 2025
  • Figure 26: Global Pain Management Therapeutics Market Attractiveness Analysis, by Region, 2015-2025
  • Figure 27: North America Pain Management Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015-2025
  • Figure 28: North America Pain Management Therapeutics Market Attractiveness Analysis, by Country, 2017- 2025
  • Figure 29: North America Pain Management Therapeutics Market Value Share Analysis, by Country, 2016 and 2025
  • Figure 30: North America Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2016 and 2025
  • Figure 31: North America Pain Management Therapeutics Market Value Share Analysis, by Opioids, 2016 and 2025
  • Figure 32: North America Pain Management Therapeutics Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 33: North America Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics, 2017-2025
  • Figure 34: North America Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2017- 2025
  • Figure 35: Europe Pain Management Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015-2025
  • Figure 36: Europe Pain Management Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2017-2025
  • Figure 37: Europe Pain Management Therapeutics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 38: Europe Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2016 and 2025
  • Figure 39: Europe Pain Management Therapeutics Market Value Share Analysis, by Opioids, 2016 and 2025
  • Figure 40: Europe Pain Management Therapeutics Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 41: Europe Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics, 2017-2025
  • Figure 42: Europe Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2017-2025
  • Figure 43: Asia Pacific Pain Management Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2015-2025
  • Figure 44: Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2017-2025
  • Figure 45: Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
  • Figure 46: Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2016 and 2025
  • Figure 47: Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Opioids, 2016 and 2025
  • Figure 48: Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 49: Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics, 2017- 2025
  • Figure 50: Asia Pacific Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2017- 2025
  • Figure 51: Rest of the World Pain Management Therapeutics Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015-2025
  • Figure 52: Rest of the World Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2016 and 2025
  • Figure 53: Rest of the World Opioids Market Value Share Analysis, by Therapeutics, 2016 and 2025
  • Figure 54: Rest of the World Pain Management Therapeutics Market Value Share Analysis, by Indication, 2016 and 2025
  • Figure 55: Rest of the World Pain Management Therapeutics Market Attractiveness Analysis, by Therapeutics, 2017-2025
  • Figure 56: Rest of the World Pain Management Therapeutics Market Attractiveness Analysis, by Indication, 2017-2025
  • Figure 57: Heat Map Analysis By Company (2016)
  • Figure 58: Pfizer Inc. Breakdown of Net Sales (2016), by Region
  • Figure 59: Pfizer Inc. Revenue (US$ Bn) & Y-o-Y Growth (%), 2014-2016
  • Figure 60: Depomed Inc. Breakdown of Net Sales for Pain Segment, 2016
  • Figure 61: Depomed Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014-2016
  • Figure 62: Endo International plc. Breakdown of Net Sales for Pain Segment, 2016
  • Figure 63: Endo International plc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014-2016
  • Figure 64: Mallinckrodt Pharmaceuticals Breakdown of Net Sales, by Business Segment, 2016
  • Figure 65: Mallinckrodt Pharmaceuticals Revenue (US$ Mn) & Y-o-Y Growth (%), 2014-2016
  • Figure 66: Novartis AG Breakdown of Net Sales, by Business Segment, 2016
  • Figure 67: Novartis AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2014-2016
  • Figure 68: Teva Pharmaceutical Breakdown of Net Sales, by Business Segment, 2016
  • Figure 69: Teva Pharmaceutical Revenue (US$ Mn) & Y-o-Y Growth (%), 2014-2016
  • Figure 70: AstraZeneca plc. Breakdown of Net Sales, by Geography 2016
  • Figure 71: AstraZeneca plc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014-2016
  • Figure 72: J&J Breakdown of Net Sales, by Geography, 2016
  • Figure 73: J&J Revenue (US$ Bn) & Y-o-Y Growth (%), 2014-2016
  • Figure 74: Merck & Co.,Inc. Breakdown of Net Sales, by Business Segment, 2016
  • Figure 75: Merck & Co.,Inc. Revenue (US$ Mn) & Y-o-Y Growth (%), 2014-2016
  • Figure 76: Abbott laboratories Breakdown of Net Sales for Pain segment, 2016
  • Figure 77: Abbott Laboratories Revenue (US$ Mn) and Y-o-Y Growth (%), 2013-2016
  • Figure 78: GlaxoSmithKline plc. Breakdown of Net Sales, by Segment, 2016
  • Figure 79: GlaxoSmithKline plc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014-2016
Back to Top